BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

608 related articles for article (PubMed ID: 12623805)

  • 21. Levofloxacin 750-mg for 5 days for the treatment of hospitalized Fine Risk Class III/IV community-acquired pneumonia patients.
    Shorr AF; Khashab MM; Xiang JX; Tennenberg AM; Kahn JB
    Respir Med; 2006 Dec; 100(12):2129-36. PubMed ID: 16730170
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
    Marple BF; Roberts CS; de Caprariis PJ; Reisman A
    Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective randomized study to determine the efficacy of preoperative topical levofloxacin in reducing conjunctival bacterial flora.
    Miño de Kaspar H; Kreutzer TC; Aguirre-Romo I; Ta CN; Dudichum J; Bayrhof M; Klauss V; Kampik A
    Am J Ophthalmol; 2008 Jan; 145(1):136-142. PubMed ID: 17996212
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammation.
    Donnenfeld ED; Holland EJ; Stewart RH; Gow JA; Grillone LR;
    Ophthalmology; 2007 Sep; 114(9):1653-62. PubMed ID: 17445902
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and efficacy of levofloxacin 750 mg for 2 weeks or 3 weeks compared with levofloxacin 500 mg for 4 weeks in treating chronic bacterial prostatitis.
    Paglia M; Peterson J; Fisher AC; Qin Z; Nicholson SC; Kahn JB
    Curr Med Res Opin; 2010 Jun; 26(6):1433-41. PubMed ID: 20394471
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy of a pelargonium sidoides preparation in patients with the common cold: a randomized, double blind, placebo-controlled clinical trial.
    Lizogub VG; Riley DS; Heger M
    Explore (NY); 2007; 3(6):573-84. PubMed ID: 18005909
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral clindamycin 300 mg BID compared with oral amoxicillin/clavulanic acid 1 g BID in the outpatient treatment of acute recurrent pharyngotonsillitis caused by group a beta-hemolytic streptococci: an international, multicenter, randomized, investigator-blinded, prospective trial in patients between the ages of 12 and 60 years.
    Mahakit P; Vicente JG; Butt DI; Angeli G; Bansal S; Zambrano D
    Clin Ther; 2006 Jan; 28(1):99-109. PubMed ID: 16490583
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy and safety of azithromycin 1.5% eye drops for purulent bacterial conjunctivitis in pediatric patients.
    Bremond-Gignac D; Mariani-Kurkdjian P; Beresniak A; El Fekih L; Bhagat Y; Pouliquen P; Delval L; Goldschmidt P; Bingen E; Cochereau I
    Pediatr Infect Dis J; 2010 Mar; 29(3):222-6. PubMed ID: 19935122
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbiological efficacy of a new ophthalmic formulation of moxifloxacin dosed twice-daily for bacterial conjunctivitis.
    Tauber S; Cupp G; Garber R; Bartell J; Vohra F; Stroman D
    Adv Ther; 2011 Jul; 28(7):566-74. PubMed ID: 21681652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy and tolerability of IV doripenem versus meropenem in adults with complicated intra-abdominal infection: a phase III, prospective, multicenter, randomized, double-blind, noninferiority study.
    Lucasti C; Jasovich A; Umeh O; Jiang J; Kaniga K; Friedland I
    Clin Ther; 2008 May; 30(5):868-83. PubMed ID: 18555934
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A multicentre, double-blind, randomised study comparing the efficacy and safety of oral levofloxacin versus ciprofloxacin in the treatment of uncomplicated skin and skin structure infections.
    Nicodemo AC; Robledo JA; Jasovich A; Neto W
    Int J Clin Pract; 1998 Mar; 52(2):69-74. PubMed ID: 9624783
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Moxifloxacin versus levofloxacin against acute exacerbations of chronic bronchitis: the Latin American Cohort.
    Urueta-Robledo J; Ariza H; Jardim JR; Caballero A; García-Calderón A; Amábile-Cuevas CF; Hernández-Oliva G; Vivar-Orozco R;
    Respir Med; 2006 Sep; 100(9):1504-11. PubMed ID: 16504492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. An open-label, double tympanocentesis study of levofloxacin therapy in children with, or at high risk for, recurrent or persistent acute otitis media.
    Arguedas A; Dagan R; Pichichero M; Leibovitz E; Blumer J; McNeeley DF; Melkote R; Noel GJ
    Pediatr Infect Dis J; 2006 Dec; 25(12):1102-9. PubMed ID: 17133154
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Moxifloxacin monotherapy is effective in hospitalized patients with community-acquired pneumonia: the MOTIV study--a randomized clinical trial.
    Torres A; Garau J; Arvis P; Carlet J; Choudhri S; Kureishi A; Le Berre MA; Lode H; Winter J; Read RC;
    Clin Infect Dis; 2008 May; 46(10):1499-509. PubMed ID: 18419482
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical and microbiological efficacy of levofloxacin administered three times a day for the treatment of bacterial conjunctivitis.
    Szaflik J; Szaflik JP; Kaminska A;
    Eur J Ophthalmol; 2009; 19(1):1-9. PubMed ID: 19123142
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Safety and efficacy of intravenous tigecycline in treatment of community-acquired pneumonia: results from a double-blind randomized phase 3 comparison study with levofloxacin.
    Bergallo C; Jasovich A; Teglia O; Oliva ME; Lentnek A; de Wouters L; Zlocowski JC; Dukart G; Cooper A; Mallick R;
    Diagn Microbiol Infect Dis; 2009 Jan; 63(1):52-61. PubMed ID: 18990531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical evaluation of ophthalmic lomefloxacin 0.3% in comparison with fortified cefazolin and gentamicin ophthalmic solutions in the treatment of presumed bacterial keratitis.
    Erjongmanee S; Kasetsuwan N; Phusitphoykai N; Puangsricharern V; Pariyakanok L
    J Med Assoc Thai; 2004 Sep; 87 Suppl 2():S83-90. PubMed ID: 16083168
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative safety profile of levofloxacin in 2523 children with a focus on four specific musculoskeletal disorders.
    Noel GJ; Bradley JS; Kauffman RE; Duffy CM; Gerbino PG; Arguedas A; Bagchi P; Balis DA; Blumer JL
    Pediatr Infect Dis J; 2007 Oct; 26(10):879-91. PubMed ID: 17901792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy and safety of besifloxacin ophthalmic suspension 0.6% in children and adolescents with bacterial conjunctivitis: a post hoc, subgroup analysis of three randomized, double-masked, parallel-group, multicenter clinical trials.
    Comstock TL; Paterno MR; Usner DW; Pichichero ME
    Paediatr Drugs; 2010 Apr; 12(2):105-12. PubMed ID: 20218747
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 31.